Ymalzen

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameYmalzen
Drug Alias NamePAT (Centre National de la Recherche Scientifique (CNRS))YMALZEN
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsDental Plaque
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversitat Internacional De Catalunya
Active IndicationsN/A
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsDental Plaque

Other Information

ATC CodeN/A
Related LinksN/A